Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Aug;5(4):475-81.
doi: 10.21037/tau.2016.05.15.

Psychosexual therapy for premature ejaculation

Affiliations
Review

Psychosexual therapy for premature ejaculation

Stanley E Althof. Transl Androl Urol. 2016 Aug.

Abstract

Premature ejaculation (PE) is a male sexual dysfunction that creates considerable anguish for the man, his partner and their relationship. PE is not one disorder but includes the four subtypes (lifelong, acquired, natural and subjective) each with unique psychological concerns and issues. Psychological treatment for men and couples with PE addresses sexual skills/techniques but also focuses on issues of self-esteem, performance anxiety and interpersonal conflict. The outcome studies for psychotherapy alone are difficult to interpret and compare because of poor methodological design (lack of control groups, small sample size, poor outcome measures and lack of follow-up). However, the few studies that surmount these methodological hurdles suggest that psychological intervention offers men and couples a promising treatment option. Combination pharmaco- and psychotherapy is the most promising intervention for lifelong and acquired PE and offers superior efficacy to drug alone. This is because men and couples learn sexual skills, address the intrapsychic, interpersonal and cognitive issues that precipitate and maintain the dysfunction.

Keywords: Premature ejaculation (PE); behavior therapy; combination therapy; psychotherapy; sex therapy.

PubMed Disclaimer

Conflict of interest statement

Dr. Althof is a consultant or Advisory Board Member to: Allergan, Aytu, Astellas, Ixchelsis, Eli Lilly, Palatin, Pfizer, Promescent, Sprout, S1, Strategic Science Technologies and Valeant. He conducts clinical trials for Allergan, Ixchelsis, Evidera, Palatin and Trimel.

Similar articles

Cited by

References

    1. Rowland DL, Patrick DL, Rothman M, et al. The psychological burden of premature ejaculation. J Urol 2007;177:1065-70. 10.1016/j.juro.2006.10.025 - DOI - PubMed
    1. Althof SE, McMahon CG, Waldinger MD, et al. An update of the International Society of Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation (PE). J Sex Med 2014;11:1392-422. 10.1111/jsm.12504 - DOI - PubMed
    1. McMahon CG, Althof SE, Waldinger MD, et al. An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculation. J Sex Med 2008;5:1590-606. 10.1111/j.1743-6109.2008.00901.x - DOI - PubMed
    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5®), Fifth Edition. Washington, DC: American Psychiatric Association, 2013.
    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision. Washington, DC: American Psychiatric Association, 2000.

LinkOut - more resources